Today's report also covers efficacy and safety of piclidenoson, identification of psoriatic arthritis in patients with psoriasis, and more (1,900 words, 8 minutes, 30 seconds)
Share this post
Deucravacitinib in Japanese patients with…
Share this post
Today's report also covers efficacy and safety of piclidenoson, identification of psoriatic arthritis in patients with psoriasis, and more (1,900 words, 8 minutes, 30 seconds)